>Original CMV peptide HLA_A0201 restricted
NLVPMVATV
>CR1 Peptide scanning results Fig. 3; 30% threshold for cytotoxicity, unless the original peptide is less than 30% cytotoxic. 
YLVPMVATV
>CR2
RLVPMVATV
>CR3
FLVPMVATV
>CR4
KLVPMVATV
>CR5
MLVPMVATV
>CR6
SLVPMVATV
>CR7
ALVPMVATV
>CR8
WLVPMVATV
>CR9
HLVPMVATV
>CR10
TLVPMVATV
>CR11
VLVPMVATV
>CR12
LLVPMVATV
>CR13
GLVPMVATV
>CR14
NMVPMVATV
>CR15
NFVPMVATV
>CR16
NKVPMVATV
>CR17
NLLPMVATV
>CR18
NLMPMVATV
>CR19
NLIPMVATV
>CR20
NLVWMVATV
>CR21
NLVIMVATV
>CR22
NLVYMVATV
>CR23
NLVPWVATV
>CR24
NLVPYVATV
>CR25
NLVPMAATV
>CR26
NLVPMIATV
>CR27
NLVPMTATV
>CR28
NLVPMVVTV
>CR29
NLVPMVTTV
>CR30
NLVPMVITV
>CR31
NLVPMVASV
>CR32
NLVPMVAPV
>CR33
NLVPMVAAV
>CR34
NLVPMVATI
>CR35
NLVPMVATL
>CR36
NLVPMVATA
>CR37
NLVPMVATT
>CR38 Table 3; more than one mutation with the original peptide. Anyhting below 50 included 
YLLPMVVSV
>CR39
YLLPMVTSV
>CR40
YLLWMVTSV